Ravindran Research Lab - Biomarkers

Ravindran Research Lab

About us | Physicians | Patients | Refer

Clinical Trials

Foquest (Study Closed)

Diagnosis: ADHD

Study: Methylphenidate hydrochloride in treatment of ADHD with and without comorbid anxiety disorder (14 Week, randomized, placebo-controlled, cross-over)

This is a two-site study designed to investigate the efficacy of flexibly dosed controlled release methylphenidate hydrochloride capsules in the treatment of adult ADHD with and without comorbid anxiety disorder including Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), Panic disorder (PD), or Agoraphobia

Inclusion:

18-65 years old
A diagnosis of childhood onset ADHD with or without comorbid diagnoses of GAD, SAD, PD, or Agoraphobia
Stable medication for 8 weeks prior

Exclusion:

Montgomery-Asberg depression rating scale (MADRS) score greater than 24
Suicidality
Substance-use disorder
PTSD
History of more than 2 failed trials of adequately dosed psychostimulants
Current psychotherapy (within 4 weeks of starting trial)